 The serial biological events following CIK cells administration to a cancer patient includes a immune activation and effective lymphocytes mostly C D3CD 5 6Tlymphocytes proliferation starting early after the first administration , b clinically measurable antitumor effect mediated by activated immune cells over weeks to months ,and c potential delayed effect on patient survival several months or even longer after the first administration. 